Vertex Pharmaceuticals Market Sentiment

Vertex Pharmaceuticals Inc

VRTXNASDAQ

Trade with Public

$547.65

3.130.57%

近くで: Aug 31, 5:00 PM EST

$548.51

3.990.73%

プレマーケット: 6:51 AM EST

M&A: Crinetics Pharmaceuticals (CRNX) was acquired by Vertex Pharmaceuticals (VRTX) on Tuesday, September 1, 2026 for $10B paid in cash

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較オプション株式レポート

Vertex Pharmaceuticals Market Sentiment

Market sentiment signals for Vertex Pharmaceuticals (VRTX): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 1.9% short float

Options Flow— N/A

Insider Activity— N/A

Analyst Consensus

Buy

33 analysts

Options Flow (P/C)

—

Avg Consensus PT

$542

-1.2%

Highest Price Target

$665

+21.2%

Morgan Stanley

Lowest Price Target

$350

-36.2%

Baird

Short Interest

1.9%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 2, 2026	Morgan Stanley	Terence Flynn—	+21.2%	$665	Reinstates	Overweight
Aug 5, 2026	Truist Securities	Danielle Brill—	+3.0%	$560 → $565	Maintained	Buy
Aug 5, 2026	Barclays	Eliana Merle—	+12.5%	$615 → $617	Maintained	Overweight
Aug 4, 2026	TD Cowen	Phil Nadeau—	+0.3%	$525 → $550	Maintained	Buy
Aug 4, 2026	Cantor Fitzgerald	Carter Gould—	+8.5%	$590 → $595	Maintained	Overweight
Aug 4, 2026	Canaccord Genuity	Whitney Ijem—	-19.4%	$436 → $442	Maintained	Hold
Jul 13, 2026	UBS	Michael Yee—	+6.7%	$545 → $585	Maintained	Buy
Jul 13, 2026	Truist Securities	Danielle Brill—	+2.1%	$542 → $560	Maintained	Buy
Jul 7, 2026	RBC Capital	Brian Abrahams—	+3.9%	$543 → $570	Maintained	Outperform
Jul 7, 2026	Baird	Brian Skorney—	-36.2%	$330 → $350	Maintained	Underperform
May 6, 2026	Barclays	Eliana Merle—	+12.1%	$607 → $615	Maintained	Overweight
May 5, 2026	Canaccord Genuity	Whitney Ijem—	-20.5%	$437 → $436	Maintained	Hold
May 5, 2026	Morgan Stanley	Terence Flynn—	+12.3%	$612 → $616	Maintained	Overweight
May 5, 2026	Bernstein	William Pickering—	+4.3%	$577 → $572	Maintained	Outperform
May 5, 2026	RBC Capital	Brian Abrahams—	-1.0%	$541 → $543	Maintained	Outperform
Apr 30, 2026	Canaccord Genuity	Whitney Ijem—	-20.3%	$441 → $437	Maintained	Hold
Apr 10, 2026	Morgan Stanley	Terence Flynn—	+11.6%	$596 → $612	Maintained	Overweight
Mar 18, 2026	Maxim Group	Naz Rahman—	+4.8%	$575	Upgrade	Hold→Buy
Mar 11, 2026	Truist Securities	Joon Lee—	-4.3%	$490 → $525	Maintained	Buy
Mar 10, 2026	Morgan Stanley	Terence Flynn—	+8.7%	$570 → $596	Maintained	Overweight
Mar 10, 2026	B of A Securities	Ying Huang—	+9.0%	$571 → $598	Maintained	Buy
Mar 10, 2026	Citigroup	Geoff Meacham—	+6.7%	$575 → $585	Maintained	Buy
Mar 10, 2026	Oppenheimer	Jay Olson—	+9.4%	$540 → $600	Maintained	Outperform
Mar 10, 2026	Jefferies	Akash Tewari—	+5.7%	$580	Initiate	Buy
Mar 10, 2026	HC Wainwright & Co.	Andrew S. Fein—	+16.9%	$591 → $641	Maintained	Buy